Related Experiment Video
Updated: May 9, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
Sepsis patients do not differ in health-related quality of life compared with other ICU patients
L Orwelius1, C Lobo, A Teixeira Pinto
1Department of Health Information and Decision Sciences, Faculty of Medicine of Porto, CIDES, Porto, Portugal; Faculty of Medicine of Porto, CINTESIS - Center for Research in Health Technologies and Health Systems, Porto, Portugal; Department of Intensive Care, Linkoping University, Linköping, Sweden; Department of Clinical and Experimental Medicine, County Council of Östergötland, Linköping, Sweden.
Introduction:
The aim of the present multicentre study is to assess health-related quality of life in patients with community-acquired sepsis, severe sepsis, or septic shock (CAS) 6 months after discharge from the intensive care unit (ICU) and to compare the health-related quality of life of the ICU survivors with CAS with ICU survivors with other ICU diagnoses.
Methods:
Prospective, multicentre study in nine combined medical and surgical ICUs in Portugal. Health-related quality of life was assessed 6 months after ICU stay, using EuroQol-5D (EQ-5D) mailed to patients. ICU-related factors were obtained from the local ICU database and the local database for the SACiUCI follow-up study.
Results:
A total of 313 (52%) surviving patients answered the questionnaire, and of these 91 (29%) were admitted for CAS. There were no significant differences in health-related quality of life between the two study groups.
Conclusion:
Patients admitted to ICU for CAS did not perceived different health-related quality of life compared with ICU patients admitted for other diagnoses.
Related Concept Videos
Asepsis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urine Studies II: Urine Culture and Sensitivity Test
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: